Safety and Efficacy Study of MT-2990 in Women With Endometriosis
Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of MT-2990 for treatment of
moderate to severe endometriosis-related pain in women with surgically diagnosed
endometriosis.
Phase:
Phase 2
Details
Lead Sponsor:
Mitsubishi Tanabe Pharma Development America, Inc.